SCHEMBL458219

SCHEMBL458219

CC(C)=CCC/C(C)=C/CCC(=O)O

nearest known ligand 0.72

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FNTA P49354 5/20 0.72
FNTB P49356 5/20 0.72
KMT2A Q03164 4/20 0.70
MAPT P10636 3/20 0.65
MEN1 O00255 3/20 0.65
TRPA1 O75762 1/20 0.65
KDM4E B2RXH2 1/20 0.63
ATM Q13315 1/20 0.63
ALOX15 P16050 3/20 0.61
CYP3A4 P08684 2/20 0.61
ALDH1A1 P00352 2/20 0.61
UGT1A1 P22309 1/20 0.61
SQLE Q14534 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10750568 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL30173637 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL2573231 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL29595985 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL1395165 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL5080365 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL20435504 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL458220 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL1952603 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL31652308 1.00 FNTA (0.72) FNTAFNTBKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 611 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514146-B1 A COMBINATION FOR USE IN THE PREPARATION OF A DRINKABLE FOAMING OR FOAMABLE LIQUID, A DEVICE AND A METHOD FOR PREPARING AND DISPENSING A DRINKABLE FOAMING OR FOAMABLE LIQUID BAR ON B V (BE) 2026-05-13 EP claimed
EP-4433566-B1 CONCENTRATED WATER-SOLUBLE POWDER DETERGENT DAERG CHIMICA S R L (IT) 2026-05-06 EP claimed
EP-4727521-A1 COSMETIC PREPARATION CONTAINING XANTHAN GUM AND ACETATES Beiersdorf AG (DE) 2026-04-22 EP claimed
US-20250352444-A1 Antimicrobial mixtures SYMRISE AG (DE) 2025-11-20 US claimed
WO-2025202181-A1 TERPENOID COMPOSITIONS AND BLENDS THEREOF EVODIABIO APS (DK) 2025-10-02 WO claimed
US-20250302728-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD SYMRISE AG (DE) 2025-10-02 US claimed
EP-4444108-B1 ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT SYMRISE AG (DE) 2025-09-10 EP claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
EP-4175486-B1 COMPOSITION COMPRISING AN OIL PHASE AND AN AQUEOUS PHASE GIVAUDAN SA (CH) 2025-08-27 EP claimed
EP-4526411-A1 FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD Symrise AG (DE) 2025-03-26 EP claimed
EP-2134377-B1 FRAGRANCE DISPENSER SYMRISE AG (DE) 2012-07-18 EP claimed
US-8191796-B2 Fragrance dispenser SYMRISE AG (DE) 2012-06-05 US claimed
US-20100287710-A1 PERFUME SYSTEMS THE PROCTER & GAMBLE COMPANY 2010-11-18 US claimed
EP-2184061-A1 Genariol as bacterial efflux pump inhibitor Universite de Corse (FR) 2010-05-12 EP claimed
US-20100056422-A1 FRAGRANCE DISPENSER SYMRISE GMBH & CO. KG (DE) 2010-03-04 US claimed
EP-2134377-A1 FRAGRANCE DISPENSER Symrise GmbH & Co. KG (DE) 2009-12-23 EP claimed
WO-2008104226-A1 FRAGRANCE DISPENSER SYMRISE GMBH & CO. KG (DE) 2008-09-04 WO claimed
EP-1898952-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) Symrise GmbH & Co. KG (DE) 2008-03-19 EP claimed
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2007-03-08 US claimed
WO-2006134160-A2 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) SYMRISE GMBH & CO. KG (DE) 2006-12-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250352444-A1 Antimicrobial mixtures LRBA, MGLL, TAS2R50 FNTA 1699/4885FNTB 1297/4885KMT2A 4634/4885
US-20070054967-A1 SYNERGISTIC MIXTURES OF AROMATIC ALCOHOLS AND DERIVATIVES THEREOF AND TROPOLONE (DERIVATIVES) NR1H3, NR1H2, CBR3 FNTA 3580/4885FNTB 1439/4885KMT2A 4035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.